Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

RECKITT BENCKISER GROUP PLC: Directorate Change


20 November 2013

DIRECTORATE CHANGE

Reckitt Benckiser Group plc (RB) today announces the appointment of Nicandro Durante as an independent non-executive director, effective 1 December 2013

Mr Durante, Brazilian/Italian, is Chief Executive Officer of British American Tobacco. (BAT), a FTSE100 company with brands sold in 180 markets. Mr Durante has had an extensive career at BAT which he joined in 1981. He has held various commercial and financial roles, becoming Chief Operating Officer in January 2008 and Chief Executive Officer in March 2011. He brings experience of a highly regulated and innovation-led industry, alongside extensive emerging markets' experience, having worked in Asia, Africa and Latin America. He adds further international diversity to the RB board.

Adrian Bellamy, Chairman of RB, commented

"The Board is delighted that Nicandro has agreed to join us. He will bring a wealth of international consumer goods and financial knowledge to the Board and I am sure he will make a significant contribution to the future success of the Company."

There are no further details required to be disclosed pursuant to Listing Rule 9.6.13 in connection with Mr Durante's appointment.

For Further Information Andraea Dawson-Shepherd

SVP Global Corporate Communication and Affairs Telephone +44 (0) 1753 217 800

Liz Richardson

Company Secretary Telephone +44 (0) 1753 217 800

About Reckitt Benckiser (RB):

Reckitt Benckiser (RB) is a global consumer goods leader in health, hygiene and home.

With a purpose of delivering innovative solutions for healthier lives and happier homes, RB is in the top 25 of companies listed on the London Stock Exchange. Today it is the global No 1 or No 2 in the majority of its fast-growing categories, driven by an exceptional rate of innovation. Its health, hygiene and home portfolio is led by 19 global Powerbrands including Nurofen, Strepsils Gaviscon, Mucinex, Durex, Scholl, Lysol, Dettol, Clearasil, Veet, Harpic, Bang, Mortein, Finish, Vanish, Woolite, Calgon, Air Wick, and French's. RB has close to half of its revenues coming from it 2 emerging market Areas and just over half from its developed market Area. Over 70% of core revenues come from the health and hygiene categories of the portfolio.

RB people and its culture are at the heart of the company's success. They have an intense drive for achievement and a desire to outperform wherever they focus, including in sustainability where the company has reduced its carbon footprint by 20% in 5 years and is now targeting to deliver a 1/3 reduction in water impact, 1/3 further reduction in carbon and to have 1/3 of its net revenue coming from more sustainable products by 2020. It is also the Save the Children charity's largest FMCG global partner, with a new partnership vision to radically reduce the world's second biggest killer of under fives, diarrhoea. RB has been recognised as a sustainability leader in the CDP Global 500 Carbon Performance Leadership Index and received a 2013 Sector Mover Sustainability Award in the 10th Sustainability Yearbook.

The company has operations in over 60 countries, with headquarters in the UK, Singapore, Dubai and Amsterdam, and sales in almost 200 countries, The company employs approximately 36,000 people worldwide.

For more information visit www.rb.com

END

-0- Nov/20/2013 13:59 GMT

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement